Coronary artery bypass grafting in young patients - insights into a distinct entity

Journal of Cardiothoracic Surgery

Issam Ismail¹  Axel Haverich¹  Saad Rustum¹  Serghei Cebotari¹  Gregor Warnecke¹  Felix Fleissner¹ 

[1] Division of Cardiac, Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany

关键词: Ischemic cardiomyopathy;    Myocardial ischemia;    Extracorporeal life support (ECLS);    Arterial grafts;    CABG;   

Others  :  1209349
DOI  :  10.1186/s13019-015-0266-1

 received in 2014-11-17, accepted in 2015-04-17,  发布年份 2015

【 摘 要 】

Objectives

Coronary artery bypass grafting (CABG) is the ‘Gold Standard’ for patients with multiple vessel coronary artery disease (CAD). Younger patients presenting with coronary artery disease requiring surgery may represent a distinct subgroup with the main goal for coronary revascularization being long term patency of the performed grafts to improve outcome.

Methods

Between January 2010 and August 2013, 126 patients below the age of 50 years underwent CABG for CAD in our hospital. We retrospectively analyzed the perioperative data and evaluated patients’ outcome.

Results

In 25% of the patients CABG was performed as an emergency procedure for STEMI or NSTEMI within 36 hours. Another 27% of the patients were operated urgently for unstable angina or myocardial infarction within the last weeks and only 48% of the patients were purely elective cases. We performed only venous bypass grafts in 12%, total arterial revascularisation in 52% of all cases and combined venous and arterial revascularization in 43%. Six patients needed cardiac support using an extracorporeal membrane oxygenation (Mortality n = 1 out of 6) and 17 patients received an intraaortic ballon pump perioperativly. Patients received 2.8 ± 1 bypass grafts overall. Overall in-hospital mortality in this cohort was low with 1% (n = 1).

Conclusions

In conclusion, the majority of the young patients below the age of 50 years present urgently for operative revascularization. Besides the potential advances regarding long term patency using total arterial revascularization, only about half of the young patients are feasible for this approach. Overall early outcome in this group is excellent with mortality below one percent.

【 授权许可】

   
2015 Fleissner et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A et al.. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013; 381(9867):629-38.
• [2]Kappetein AP, Feldman TE, Mack MJ, Morice MC, Holmes DR, Ståhle E et al.. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-Year follow-up of the SYNTAX trial. Eur Heart J. 2011; 32:2125-34.
• [3]D’Errigo P, Seccareccia F, Barone AP, Fusco D, Rosato S, Maraschini A et al.. Effectiveness of invasive reperfusion therapy and standard medical treatment in AMI. Acta Cardiol. 2010; 65:645-52.
• [4]Locker C, Schaff HV, Dearani JA, Joyce LD, Park SJ, Burkhart HM et al.. Multiple arterial grafts improve late survival of patients undergoing coronary artery bypass graft surgery: analysis of 8622 patients with multivessel disease. Circulation. 2012; 126:1023-30.
• [5]Buth KJ, Gainer RA, Legare JF, Hirsch GM. The changing face of cardiac surgery: practice patterns and outcomes 2001–2010. Can J Cardiol. 2014; 30(2):224-30.
• [6]Kurlansky P. Do octogenarians benefit from coronary artery bypass surgery: a question with a rapidly changing answer? Curr Opin Cardiol. 2012; 27(6):611-9.
• [7]Vasques F, Lucenteforte E, Paone R, Mugelli A, Biancari F. Outcome of patients aged ≥80 years undergoing combined aortic valve replacement and coronary artery bypass grafting: a systematic review and meta-analysis of 40 studies. Am Heart J. 2012; 164(3):410-418.e1.
• [8]D’Errigo P, Biancari F, Maraschini A, Rosato S, Badoni G, Seccareccia F. Thirty-day mortality after coronary artery bypass surgery in patients aged <50 years: results of a multicenter study and meta-analysis of the literature. J Card Surg. 2013; 28(3):207-11.
• [9]Weintraub WS, Grau-Sepulveda MV, Weiss JM, O’Brien SM, Peterson ED, Kolm P et al.. Comparative effectiveness of revascularization strategies. N Engl J Med. 2012; 366:1467-76.
• [10]Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M et al.. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012; 367:2375-84.
• [11]Epstein AJ, Polsky D, Yang F, Yang L, Groeneveld PW. Coronary revascularization trends in the United States, 2001–2008. JAMA. 2011; 305:1769-76.
• [12]Hayward PA, Buxton BF. Contemporary coronary graft patency: 5-year observational data from a randomized trial of conduits. Ann Thorac Surg. 2007; 84:795-9.
• [13]Collins P, Webb CM, Chong CF, Moat NE. Radial Artery Versus Saphenous Vein Patency Trial Investigators. Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up. Circulation. 2008; 117:2859-64.
• [14]Deb S, Cohen EA, Singh SK, Une D, Laupacis A, Fremes SERAPS. Investigators. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). J Am Coll Cardiol. 2012; 60:28-35.
• [15]Schwann TA, Al-Shaar L, Engoren M, Habib RH. Late effects of radial artery vs. saphenous vein grafting for multivessel coronary bypass surgery in diabetics: a propensity-matched analysis. Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezt061. Published online ahead of print 21 February 2013.
• [16]Zacharias A, Habib RH, Schwann TA, Riordan CJ, Durham SJ, Shah A. Improved survival with radial artery versus vein conduits in coronary bypass surgery with left internal thoracic artery to left anterior descending artery grafting. Circulation. 2004; 109:1489-96.
• [17]Khawaja FJ, Rihal CS, Lennon RJ, Holmes DR, Prasad A. Temporal trends (over 30 years), clinical characteristics, outcome, and gender in patients _50 years of age having percutaneous coronary intervention. Am J Cardiol. 2011; 107:668-74.